Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: RTO=Reverse Take Over

But assuming that your 50% of all rights is accurate, then the correct ownership is TPL 25%, Moore 25%, PTSC 50%.  Others like S&L having a temporary assignment, I believe.  If that is correct, then in a reverse merger of Intellasys with PTSC, TPL would only need to reimbursed for the 25% of the MMP, not 50% of it.  That assumes Moore comes over with Intellasys.  Am I off base with that thinking?  Opty

 

Share
New Message
Please login to post a reply